Does ADALIMUMAB Cause Gastrointestinal carcinoma? 142 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Gastrointestinal carcinoma have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
142
Reports of Gastrointestinal carcinoma with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
24
Deaths
60
Hospitalizations
How Dangerous Is Gastrointestinal carcinoma From ADALIMUMAB?
Of the 142 reports, 24 (16.9%) resulted in death, 60 (42.3%) required hospitalization, and 6 (4.2%) were considered life-threatening.
Is Gastrointestinal carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 142 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Gastrointestinal carcinoma?
RANITIDINE (6,475)
INFLIXIMAB (96)
CLOZAPINE (73)
VEDOLIZUMAB (54)
USTEKINUMAB (47)
ETANERCEPT (43)
LEUPROLIDE (41)
OCTREOTIDE (36)
RISANKIZUMAB-RZAA (35)
APIXABAN (33)
Which ADALIMUMAB Alternatives Have Lower Gastrointestinal carcinoma Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB